Feto-placental morphological effects of prenatal exposure to drugs of abuse

Informe anual. Observatorio Europeo de las Drogas y Toxicomanías; 2009. Birchfield, 1995, Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area, Journal of Perinatology, 15, 208 Lester, 2001, The maternal lifestyle study: drug use by meconium toxicology and maternal self-report, Pediatrics, 107, 309, 10.1542/peds.107.2.309 Bar-Oz, 2003, Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse, Archives of Disease in Childhood Fetal and Neonatal Edition, 88, F98, 10.1136/fn.88.2.F98 Gillogley, 1990, The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening, American Journal of Obstetrics and Gynecology, 163, 1535, 10.1016/0002-9378(90)90621-D Garcia-Algar, 2009, Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona, Anales de Pediatria (Barcelona, Spain), 70, 151 Garcia-Algar, 2008, Alarming prevalence of fetal alcohol exposure in a Mediterranean city, Therapeutic Drug Monitoring, 30, 249, 10.1097/FTD.0b013e31816a8657 Levy, 1990, Obstetric and neonatal effects of drugs of abuse, Emergency Medicine Clinics of North America, 8, 633, 10.1016/S0733-8627(20)30264-9 Schempf, 2007, Illicit drug use and neonatal outcomes: a critical review, Obstetrical and Gynecological Survey, 62, 749, 10.1097/01.ogx.0000286562.31774.76 Shankaran, 2007, Impact of maternal substance use during pregnancy on childhood outcome, Seminars in Fetal and Neonatal Medicine, 12, 143, 10.1016/j.siny.2007.01.002 Chasnoff, 1986, Perinatal cerebral infarction and maternal cocaine use, Journal of Pediatrics, 108, 456, 10.1016/S0022-3476(86)80896-4 Chasnoff, 1989, Cocaine: clinical studies of pregnancy and the newborn, Annals of the New York Academy of Sciences, 562, 260, 10.1111/j.1749-6632.1989.tb21024.x Ellis, 1993, In utero exposure to cocaine: a review, Southern Medical Journal, 86, 725, 10.1097/00007611-199307000-00001 Winklbaur, 2008, Opioid dependence and pregnancy, Current Opinion in Psychiatry, 21, 255, 10.1097/YCO.0b013e3282fb25e5 Sokol, 2003, Fetal alcohol spectrum disorder, Journal of the American Medical Association, 290, 2996, 10.1001/jama.290.22.2996 Andres, 2000, Perinatal complications associated with maternal tobacco use, Seminars in Neonatology, 5, 231, 10.1053/siny.2000.0025 Kuczkowski, 2007, The effects of drug abuse on pregnancy, Current Opinion in Obstetrics and Gynecology, 19, 578, 10.1097/GCO.0b013e3282f1bf17 Pichini, 2005, Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the “Meconium Project”, Forensic Science International, 153, 59, 10.1016/j.forsciint.2005.04.013 Chan, 2003, Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto, Therapeutic Drug Monitoring, 25, 271, 10.1097/00007691-200306000-00004 Pichini, 2000, Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy, Environmental Health Perspectives, 108, 1079, 10.1289/ehp.001081079 Nafstad, 1996, Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum, Acta Obstetricia et Gynecologica Scandinavica, 75, 902, 10.3109/00016349609055025 Demir, 1994, Structural changes in placental barrier of smoking mother. A quantitative and ultrastructural study, Pathology Research and Practice, 190, 656, 10.1016/S0344-0338(11)80744-2 Jauniaux, 2007, Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit, Early Human Development, 83, 699, 10.1016/j.earlhumdev.2007.07.016 Christianson, 1979, Gross differences observed in the placentas of smokers and nonsmokers, American Journal of Epidemiology, 110, 178, 10.1093/oxfordjournals.aje.a112802 Kopp, 1982, Histologic and morphometric findings in placentas of heroin addicts (author's transl), Zeitschrift fur Geburtshilfe und Perinatologie, 186, 37 Vavrinkova, 2001, Placental and umbilical cord changes in drug-addicted women, Ceska Gynekologie, 66, 345 Gundogan, 2008, Impaired placentation in fetal alcohol syndrome, Placenta, 29, 148, 10.1016/j.placenta.2007.10.002 Kaminski, 1978, Alcohol consumption in pregnant women and the outcome of pregnancy, Alcoholism: Clinical and Experimental Research, 2, 155, 10.1111/j.1530-0277.1978.tb04716.x Hollstedt, 1983, Outcome of pregnancy in women treated at an alcohol clinic, Acta Psychiatrica Scandinavica, 67, 236, 10.1111/j.1600-0447.1983.tb06737.x Plessinger, 1993, Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy, Clinical Obstetrics and Gynecology, 36, 267, 10.1097/00003081-199306000-00008 Patel, 1999, Cocaine decreases uteroplacental blood flow in the rat, Neurobehavioral Toxicology and Teratology, 21, 559, 10.1016/S0892-0362(99)00022-7 Woods, 1998, Maternal and transplacental effects of cocaine, Annals of the New York Academy of Sciences, 846, 1, 10.1111/j.1749-6632.1998.tb09722.x Cejtin, 1999, Effects of cocaine on the placenta, Pediatric and Developmental Pathology, 2, 143, 10.1007/s100249900102 Salhab, 1994, Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration, Journal of Pharmacology and Experimental Therapeutics, 270, 392 Gilbert, 1990, Lack of specific placental abnormality associated with cocaine use, American Journal of Obstetrics and Gynecology, 163, 998, 10.1016/0002-9378(90)91112-P Mooney, 1998, Placental pathology in patients using cocaine: an observational study, Obstetrics and Gynecology, 91, 925, 10.1016/S0029-7844(98)00055-6 Ashfaq, 2003, Effects of maternal smoking on placental morphology, Journal of Ayub Medical College, Abbottabad, 15, 12 Mochizuki, 1984, Effects of smoking on fetoplacental–maternal system during pregnancy, American Journal of Obstetrics and Gynecology, 149, 413, 10.1016/0002-9378(84)90156-X Burton, 1989, Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers, British Journal of Obstetrics and Gynaecology, 96, 907, 10.1111/j.1471-0528.1989.tb03344.x Vogt Isaksen, 2004, Maternal smoking, intrauterine growth restriction, and placental apoptosis, Pediatric and Developmental Pathology, 7, 433, 10.1007/s10024-004-0105-1 Asmussen, 1977, Ultrastructure of the human placenta at term, Observations on placentas from newborn children of smoking and non-smoking mothers, Acta Obstetricia et Gynecologica Scandinavica, 56, 119, 10.3109/00016347709158353 Ganapathy, 1994, Human placenta: a direct target for cocaine action, Placenta, 15, 785, 10.1016/S0143-4004(05)80181-X Larsen, 2002, Stereologic examination of placentas from mothers who smoke during pregnancy, American Journal of Obstetrics and Gynecology, 186, 531, 10.1067/mob.2002.120481 van der Veen, 1982, The effects of cigarette smoking on the human placenta: a light and electron microscopic study, Placenta, 3, 243, 10.1016/S0143-4004(82)80002-7 Siler-Khodr, 2000, Effect of ethanol on thromboxane and prostacyclin production in the human placenta, Alcohol, 21, 169, 10.1016/S0741-8329(00)00084-7 Altura, 1982, Alcohol produces spasms of human umbilical blood vessels: relationship to fetal alcohol syndrome (FAS), European Journal of Pharmacology, 86, 311, 10.1016/0014-2999(82)90335-1 Acevedo, 2001, Ethanol inhibits l-arginine uptake and enhances NO formation in human placenta, Life Sciences, 68, 2893, 10.1016/S0024-3205(01)01070-0 Kay, 2000, Ethanol exposure induces oxidative stress and impairs nitric oxide availability in the human placental villi: a possible mechanism of toxicity, American Journal of Obstetrics and Gynecology, 182, 682, 10.1067/mob.2000.104201 Savoy-Moore, 1989, Low dose alcohol contracts the human umbilical artery in vitro, Alcoholism: Clinical and Experimental Research, 13, 40, 10.1111/j.1530-0277.1989.tb00281.x Acevedo, 1997, Endogenous nitric oxide attenuates ethanol-induced vasoconstriction in the human placenta, Gynecologic and Obstetric Investigation, 44, 153, 10.1159/000291509 Myatt, 1992, Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal–placental circulation, American Journal of Obstetrics and Gynecology, 166, 224, 10.1016/0002-9378(92)91863-6 Vucinovic, 2008, Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience, Yonsei Medical Journal, 49, 705, 10.3349/ymj.2008.49.5.705 Thaithumyanon, 2005, Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant, Journal of the Medical Association of Thailand, 88, 1506 Zdravkovic, 2005, The adverse effects of maternal smoking on the human placenta: a review, Placenta, 26, S81, 10.1016/j.placenta.2005.02.003 Chasnoff, 1985, Cocaine use in pregnancy, The New England Journal of Medicine, 313, 666, 10.1056/NEJM198509123131105 Kain, 1993, Cocaine abuse in the parturient and effects on the fetus and neonate, Anesthesia and Analgesia, 77, 835, 10.1213/00000539-199310000-00030 Sokol, 1980, Alcohol abuse during pregnancy: an epidemiologic study, Alcoholism: Clinical and Experimental Research, 4, 135, 10.1111/j.1530-0277.1980.tb05628.x 1993, Effects of in utero exposure to street drugs, American Journal of Public Health, 83, 1 Dombrowski, 1991, Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor, Obstetrics and Gynecology, 77, 139 Addis, 2001, Fetal effects of cocaine: an updated meta-analysis, Reproductive Toxicology, 15, 341, 10.1016/S0890-6238(01)00136-8 Lozano, 2007, Biological matrices for the evaluation of in utero exposure to drugs of abuse, Therapeutic Drug Monitoring, 29, 711, 10.1097/FTD.0b013e31815c14ce Burd, 2008, Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium, Birth Defects Research. Part A, Clinical and Molecular Teratology, 82, 487, 10.1002/bdra.20464 Gray, 2009, Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study, Therapeutic Drug Monitoring, 31, 769, 10.1097/FTD.0b013e3181bb438e